GENX.US Genex Pharmaceutical Inc

Healthcare Pharmaceuticals USA Stocks
- USD
Market cap
-
P/E
-
P/B
0.08x
ROE
7.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2007.

Is GENX.US undervalued?

Graham number

The Graham number of Genex Pharmaceutical Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Genex Pharmaceutical Inc fundamental analysis

No fundamental analysis for Genex Pharmaceutical Inc yet.

Genex Pharmaceutical Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Genex Pharmaceutical Inc

Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People's Republic of China.

Full company profile